Modern Neoliberal Philanthropy: motivations and impact of Pfizer Pharmaceutical’s corporate social responsibility campaign

Michael Givel

Third World Quarterly, 2013, vol. 34, issue 1, 171-182

Abstract: One of Pfizer Pharmaceutical’s general corporate goals is that no person anywhere should be restricted from receiving essential and affordable medicines. From 2009 to 11 Pfizer’s internal corporate social responsibility (csr) programmes were private corporate efforts that were discretionary and limited in scope and impact. All Pfizer’s csr preferred public policy governmental positions encompassed neoliberal government requirements based on market and profit considerations, with no positions demonstrating, in detail, how universal provision of drugs for all would be provided. Currently Pfizer’s csr efforts represent a dichotomy when compared with the general corporate goal of not restricting essential and affordable medicines in order to provide medicines for all.

Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/01436597.2012.755013 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:ctwqxx:v:34:y:2013:i:1:p:171-182

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/ctwq20

DOI: 10.1080/01436597.2012.755013

Access Statistics for this article

Third World Quarterly is currently edited by Shahid Qadir

More articles in Third World Quarterly from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().